Company Statement: Grifols and Talecris Biotherapeutics announce the FTC has accepted the consent agreement for public comment
MLex Summary: Grifols and Talecris have announced the deal received official approval from the Federal Trade Commission after agreeing to divest certain assets to Italian rival, Kedrion. Company press release follows...To view the full article, register now.
Already a subscriber? Click here to view full article